Università Federico II, Napoli, Napoli, Italy.
Parkinsonism Relat Disord. 2009 Sep;15(8):576-81. doi: 10.1016/j.parkreldis.2009.02.004. Epub 2009 Apr 10.
To assess the psychometric properties of the Italian version of the Snaith-Hamilton Pleasure Scale (SHAPS) and to study the relationship between anhedonia, depression and cognitive impairment in patients with Parkinson's disease (PD).
The SHAPS (14 items) was translated into Italian and pre-tested in a pilot study. Two items evaluating physical anhedonia related to sexual issues were added. The Italian version of SHAPS was validated in 274 consecutive PD patients, divided into patients with major depression according to DSM-IV criteria (dPD) and patients without depression (nPD), and in healthy subjects. To test the feasibility of the instrument and to determine whether clinical data affect anhedonia, we also administered SHAPS to 1307 patients with different types of parkinsonism.
The Italian SHAPS proved to be easy to understand as regards the question and answer modes. Intraclass coefficient for test-retest reliability was 0.65 for the total score. KR index was 0.61. ANOVA of the SHAPS total score revealed that scores were higher in dPD patients than in healthy controls and nPD (p<0.05). In the 1307 patients with various types of parkinsonism, the SHAPS data showed that anhedonia was related to age, type of parkinsonism, apathy, depression and cognitive impairment. Anhedonia was correlated with frontal dysfunctions in supranuclear palsy and PD patients (r=-0.682 and -0.264 respectively, p<0.05).
The Italian version of the SHAPS is a reliable tool with which to assess anhedonia in patients with PD and other forms of parkinsonism.
评估意大利版 Snaith-Hamilton 快感量表(SHAPS)的心理测量特性,并研究帕金森病(PD)患者快感缺失、抑郁和认知障碍之间的关系。
SHAPS(14 项)被翻译成意大利语,并在预试验中进行了测试。增加了两项评估与性问题相关的身体快感缺失的项目。意大利版 SHAPS 在 274 例连续 PD 患者中进行了验证,这些患者根据 DSM-IV 标准分为有重度抑郁症的患者(dPD)和无抑郁症的患者(nPD),并在健康受试者中进行了验证。为了测试该工具的可行性并确定临床数据是否会影响快感缺失,我们还向 1307 例不同类型的帕金森病患者发放了 SHAPS。
意大利版 SHAPS 在问题和答案模式方面被证明易于理解。重测信度的内类系数为 0.65。KR 指数为 0.61。SHAPS 总分的 ANOVA 显示,dPD 患者的得分高于健康对照组和 nPD 患者(p<0.05)。在 1307 例不同类型的帕金森病患者中,SHAPS 数据表明,快感缺失与年龄、帕金森病类型、淡漠、抑郁和认知障碍有关。快感缺失与核上性麻痹和 PD 患者的额功能障碍有关(r=-0.682 和-0.264,分别为 p<0.05)。
意大利版 SHAPS 是一种可靠的工具,可用于评估 PD 患者和其他形式的帕金森病患者的快感缺失。